108 related articles for article (PubMed ID: 11055341)
21. Novel thrombin inhibitors incorporating non-basic partially saturated heterobicyclic P1-arginine mimetics.
Peterlin-Masic L; Mlinsek G; Solmajer T; Trampus-Bakija A; Stegnar M; Kikelj D
Bioorg Med Chem Lett; 2003 Mar; 13(5):789-94. PubMed ID: 12617892
[TBL] [Abstract][Full Text] [Related]
22. Specificity and reactive loop length requirements for crmA inhibition of serine proteases.
Tesch LD; Raghavendra MP; Bedsted-Faarvang T; Gettins PG; Olson ST
Protein Sci; 2005 Feb; 14(2):533-42. PubMed ID: 15632287
[TBL] [Abstract][Full Text] [Related]
23. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
24. Selection of new chromogenic substrates of serine proteinases using combinatorial chemistry methods.
Wysocka M; Kwiatkowska B; Rzadkiewicz M; Lesner A; Rolka K
Comb Chem High Throughput Screen; 2007 Mar; 10(3):171-80. PubMed ID: 17346116
[TBL] [Abstract][Full Text] [Related]
25. Highly sensitive peptide-4-methylcoumaryl-7-amide substrates for blood-clotting proteases and trypsin.
Kawabata S; Miura T; Morita T; Kato H; Fujikawa K; Iwanaga S; Takada K; Kimura T; Sakakibara S
Eur J Biochem; 1988 Feb; 172(1):17-25. PubMed ID: 3278905
[TBL] [Abstract][Full Text] [Related]
26. New class of sensitive and selective fluorogenic substrates for serine proteinases. Amino acid and dipeptide derivatives of rhodamine.
Leytus SP; Patterson WL; Mangel WF
Biochem J; 1983 Nov; 215(2):253-60. PubMed ID: 6228222
[TBL] [Abstract][Full Text] [Related]
27. Novel non-covalent thrombin inhibitors incorporating P(1) 4,5,6,7-tetrahydrobenzothiazole arginine side chain mimetics.
Marinko P; Krbavcic A; Mlinsek G; Solmajer T; Bakija AT; Stegnar M; Stojan J; Kikelj D
Eur J Med Chem; 2004 Mar; 39(3):257-65. PubMed ID: 15051174
[TBL] [Abstract][Full Text] [Related]
28. Specificity assay of serine proteinases by reverse-phase high-performance liquid chromatography analysis of competing oligopeptide substrate library.
Antal J; Pál G; Asbóth B; Buzás Z; Patthy A; Gráf L
Anal Biochem; 2001 Jan; 288(2):156-67. PubMed ID: 11152586
[TBL] [Abstract][Full Text] [Related]
29. Amide and alpha-keto carbonyl inhibitors of thrombin based on arginine and lysine: synthesis, stability and biological characterization.
Brady SF; Sisko JT; Stauffer KJ; Colton CD; Qiu H; Lewis SD; Ng AS; Shafer JA; Bogusky MJ; Veber DF
Bioorg Med Chem; 1995 Aug; 3(8):1063-78. PubMed ID: 7582980
[TBL] [Abstract][Full Text] [Related]
30. Substrate specificity of a novel serine protease from soybean [Glycine max (L.) Merrill].
Morita S; Fukase M; Yamaguchi M; Morita Y
J Biochem; 1996 Jun; 119(6):1094-9. PubMed ID: 8827443
[TBL] [Abstract][Full Text] [Related]
31. D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety.
Lange UE; Baucke D; Hornberger W; Mack H; Seitz W; Höffken HW
Bioorg Med Chem Lett; 2003 Jun; 13(12):2029-33. PubMed ID: 12781189
[TBL] [Abstract][Full Text] [Related]
32. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
33. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
34. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease.
Tong L; Qian C; Massariol MJ; Déziel R; Yoakim C; Lagacé L
Nat Struct Biol; 1998 Sep; 5(9):819-26. PubMed ID: 9731777
[TBL] [Abstract][Full Text] [Related]
35. The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position.
Baettig U; Brown L; Brundish D; Dell C; Furzer A; Garman S; Janus D; Kane PD; Smith G; Walker CV; Cockcroft X; Ambler J; Mitchelson A; Talbot MD; Tweed M; Wills N
Bioorg Med Chem Lett; 2000 Jul; 10(14):1563-6. PubMed ID: 10915051
[TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of novel trypsin-like serine proteases from mouse spleen.
Fukusen N; Aoki Y
J Biochem; 1996 Apr; 119(4):633-8. PubMed ID: 8743562
[TBL] [Abstract][Full Text] [Related]
37. Heparin and protease inhibition. I. Heparin complexes with thrombin, plasmin, and trypsin.
Smith GF; Sundboom JL
Thromb Res; 1981 Apr 1-15; 22(1-2):103-14. PubMed ID: 6457413
[No Abstract] [Full Text] [Related]
38. A novel venombin B from agkistrodon contortrix contortrix: evidence for recognition properties in the surface around the primary specificity pocket different from thrombin.
Amiconi G; Amoresano A; Boumis G; Brancaccio A; De Cristofaro R; De Pascalis A; Di Girolamo S; Maras B; Scaloni A
Biochemistry; 2000 Aug; 39(33):10294-308. PubMed ID: 10956019
[TBL] [Abstract][Full Text] [Related]
39. Purification, characterization, and localization of a novel trypsin-like protease found in the human airway.
Yasuoka S; Ohnishi T; Kawano S; Tsuchihashi S; Ogawara M; Masuda K; Yamaoka K; Takahashi M; Sano T
Am J Respir Cell Mol Biol; 1997 Mar; 16(3):300-8. PubMed ID: 9070615
[TBL] [Abstract][Full Text] [Related]
40. Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.
Wang G; Goyal N; Hopkinson B
Bioorg Med Chem Lett; 2009 Jul; 19(14):3798-803. PubMed ID: 19447619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
